These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 12829982)

  • 1. Ribavirin as maintenance therapy for hepatitis C patients: an interim peacekeeper?
    Patel K; Dev A; Muir AJ; McHutchison JG
    Hepatology; 2003 Jul; 38(1):21-4. PubMed ID: 12829982
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
    Soza A; Hoofnagle JH
    Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
    [No Abstract]   [Full Text] [Related]  

  • 3. [The importance of using ribavirin in treating chronic hepatitis C].
    Xie Y; Li MH
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):930-1. PubMed ID: 17196140
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C in hemophilic patients.
    Husa P; Smejkal P; Husová L; Penka M
    Acta Virol; 2004; 48(1):35-8. PubMed ID: 15230473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis C virus: the first decade.
    Poynard T
    Semin Liver Dis; 2004; 24 Suppl 2():19-24. PubMed ID: 15346242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
    Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenic effects of ribavirin in vivo.
    Perelson AS; Ribeiro RM
    J Hepatol; 2005 Oct; 43(4):553-5. PubMed ID: 16099528
    [No Abstract]   [Full Text] [Related]  

  • 10. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C: current and future therapies.
    Mishra P; Jensen DM
    Mt Sinai J Med; 2008 Aug; 75(4):405-14. PubMed ID: 18729159
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
    Husa P; Roznovsky L; Smejkal P; Husova L; Penka M; Dite P
    Hepatogastroenterology; 2005; 52(65):1541-4. PubMed ID: 16201114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options.
    Papatheodoridis GV; Cholongitas E
    J Viral Hepat; 2004 Jul; 11(4):287-96. PubMed ID: 15230850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
    Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.
    Honda T; Katano Y; Urano F; Murayama M; Hayashi K; Ishigami M; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
    J Gastroenterol Hepatol; 2007 Jul; 22(7):989-95. PubMed ID: 17608843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of chronic hepatitis in 2008].
    Pol S; Marcellin P
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S71-3. PubMed ID: 18675183
    [No Abstract]   [Full Text] [Related]  

  • 17. [Patients on maintenance therapy for opiate dependence should be treated for hepatitis C].
    Dalgard O; Skrede S
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498-9; author reply 2499. PubMed ID: 19997143
    [No Abstract]   [Full Text] [Related]  

  • 18. The next step for taribavirin.
    Kwo PY; Vinayek R
    Hepatology; 2010 Oct; 52(4):1185-8. PubMed ID: 20879028
    [No Abstract]   [Full Text] [Related]  

  • 19. Ribavirin and immune thrombocytopenic purpura.
    Jaccard A; Loustaud V; Turlure P; Rogez S; Bordessoule D
    Lancet; 1998 May; 351(9116):1660-1. PubMed ID: 9620744
    [No Abstract]   [Full Text] [Related]  

  • 20. With all the new treatment regimens, complete elimination of hepatitis C virus in Canada is a possibility! But when will Canadians have access these drugs?
    Peltekian KM
    Can J Gastroenterol Hepatol; 2014 Sep; 28(8):417-8. PubMed ID: 25229463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.